Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
J Am Coll Cardiol
; 62(20): 1826-33, 2013 Nov 12.
Article
en En
| MEDLINE
| ID: mdl-23973693
Palabras clave
ACS; ATP; Adult Treatment Panel; BMI; CETP; HDL cholesterol; HDL-C; LDL-C; MI; OMT; PCI; SIHD; acute coronary syndrome(s); body mass index; cholesteryl ester transfer protein; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; myocardial infarction; optimal medical therapy; percutaneous coronary intervention; residual risk; stable ischemic heart disease
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Isquemia Miocárdica
/
HDL-Colesterol
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Am Coll Cardiol
Año:
2013
Tipo del documento:
Article